Healthcare

The Indian hospital industry accounting for 80% of the total healthcare market is expected to touch US$ 132 billion by 2023

Last updated: December 6, 2022

The digital healthcare market is estimated to reach INR 485.43 bn by 2024

US$ 372 bn

Expected valuation of Indian healthcare sector by the end of 2022

US$ 11.28 billion

allocated to the Ministry of Health and Family Welfare (MoHFW) in Budget 2022

2.1% of GDP

Public expenditure on healthcare

US$ 13.42 bn

Projected valuation of Indian medical tourism market by 2026

Ayushman Bharat

aims to provide annual healthcare coverage of nearly US$7,000 per family, benefiting more than 500 million vulnerable people.

33.33%

share in the total gross written premiums earned in the country

US$ 4.32 billion

M&A activity for the healthcare and pharmaceutical sector in India in the first half of 2022

93 lakh

number of policies issued to women in FY21

US$ 19.41 bn

FDI inflows for the drugs and pharmaceuticals sector between April 2000-March 2022

National Health Policy

The primary aim of the policy is to inform, clarify, strengthen and prioritize the role of the Government in shaping health systems in all its dimensions.
Ayushman Bharat

The programme aims to provide annual healthcare coverage of nearly US$7,000 per families, benefiting more than 500 million vulnerable people.
Rashtriya Arogya Nidhi

The RAN was set up to provide financial assistance to patients, living below poverty line and those who are suffering from major life threatening diseases, to receive medical treatment at any of the super specialty hospitals/institutes or other Government hospitals.
National AYUSH Mission

The NAM is being implemented by Ministry of AYUSH with the objective of providing cost effective AYUSH services.
COVID-19 Research for Diagnostics, Vaccines and Therapeutics

A Research strategy has been evolved at the Department of Biotechnology (DBT) for immediate response and long-term preparedness to combat COVID-19 infection.

Rashtriya Arogya Nidhi

The RAN was set up to provide financial assistance to patients, living below poverty line and who are suffering from major life threatening diseases, to receive medical treatment at any of the super speciality Hospitals/Institutes or other Government hospitals.

Scheme for Development of Ayush Clusters

The industry, that has approximate annual turnover of US$ 1.61 bn is essentially dominated by micro, small and medium enterprises (MSMEs) which account for more than 80% of the enterprises that are located in identifiable geographical clusters.
Central Sector Scheme on Conservation, Development and Sustainable Management of Medicinal Plants

India is home to diverse range of medicinal plants which have been used for centuries by the local people to meet not only their own primary health care needs but also to address ailments of domesticated animals (Pashuayurveda) & crops.

Central Sector Scheme for Promotion of Information, Education, and Communication (IEC) in AYUSH

Though AYUSH systems of medicine are popular and progressively a large section of population uses these systems for health care, there is lack of awareness among the general public about remedies available in these systems.

lndia COVlD-19 Emergency Flesponse and Health system pneparedness package

With a proposed investment amount of US$ 2.4 bn, the Package is to be implemented in three stages.

The National Commission for Indian System of Medicine Bill, 2020

The Bill proposes the institution of a 29 member body called the National Commission for Indian System of Medicine (NCISM) which will serve as a regulatory body for the system at large.
The National Commission for Homoeopathy Bill, 2020

The Bill aims to facilitate adequate resources for homeopathy education and the subsequent state-wide institution of regulatory councils in the National Commission for Homoeopathy (NCH).

Cabinet approves the extension of the Scheme for Financial Support to Public Private Partnerships

The revamped Schemes would be applicable to the Social Infrastructure domain including Healthcare, Education and Water Treatment. 30% of the Total Project Cost is to be taken up by the Central Government.

Association of Healthcare Providers (India)

+91-11-23379651

Visit Website

The vison of the Association is to have a healthy India, encompassing society, community and common man at the grassroots.

Medical Technology Association of India

+91 124 4382629

Visit Website

MTaI is an association of research-based medical technology companies who have made remarkable investments by setting up a large number of R&D centres and manufacturing plants in India.

Indian Home & Personal Care Industry Association

+91-22-28741366

Visit Website

The Association represents the Home & Personal Care (HPC) industry and provides a platform for National & International networking and interaction with regulatory bodies.

Indian Medical Association

+91-11-23370009, +91-9999116375

Visit Website

Indian Medical Association is the only representative, national voluntary organisation of Doctors of Modern Scientific System of Medicine, which looks after the interest of doctors as well as the well being of the community at large..

Ministry of Health and Family Welfare

Investment Opportunities

  • Government of India is setting up multiple campuses of All India Institute of Medical Sciences (AIIMS).
  • India has come up as one of the leading destinations for high-end diagnostic services with strong investment.
  • Vast opportunities in setting up and expanding drug formulation R&D as well as testing activity.
  • Investment opportunities in building world-class hospitals, as well as training of human resources required.
  • Opportunities in medical tourism promotion, infrastructure and services drawing foreign visitors.
Useful Links:

Key Investors

India has a well-oiled enterprise promoting machinery that is backed by strong legislative, judiciary, executive and capital establishments

American drugmaker Merck operates a manufacturing plant in India.

French drugmaker Sanofi operates a manufacturing plant in Goa.

UK's GlaxoSmithKline operates R&D and manufacturing in India.

Singapore's 4CE Ventures has invested in Indian health tech startups.

ENABLING ENVIRONMENT

India has a well-oiled enterprise promoting machinery that is backed by strong legislative, judiciary, executive, and capital establishments

PM launches India’s first 5G testbed Read More
Auto, pharma, engineering exports to UAE will grow through trade pact Read More
Kargil and Leh to be developed into Smart Cities Read More
Applications for PLI scheme for white goods reopened Read More
RBI rolls out four-tier demarcation for the NBFC landscape Read More
Electric Vehicles dominate estimates of new vehicle sales by 2025 Read More

News

Indian startups geared to scale up globally: Report
November 22, 2022

India has 81,000 government-recognized startups across 656 districts, making it …

Read More

60% of all the Covid vaccines used globally are produced in India: Finance Minister
August 18, 2022

Almost 60% of all the vaccines for the coronavirus used …

Read More

India’s bio-economy grows to US$ 80 billion in eight years: PM
June 10, 2022

India’s ‘bio economy’ has grown eight times in the last …

Read More
View All

Events

Jan 30,2023

FUTURE OF MOBILITY : India`s Journey towards Net Zero
Jan 31,2023

ASSOCHAM Southern Region Presents 3rd Edition CSR and Sustainability Awards 2022
Feb 07,2023

Expos and Fairs in Mexico in 2023
Feb 09,2023

46th Joint Meeting of India-Japan Business Cooperation Committee (IJBCC)
View More